These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3530092)

  • 1. Toxicity of aluminium in biological model systems.
    De Boni U
    Ann Ist Super Sanita; 1986; 22(2):685-8. PubMed ID: 3530092
    [No Abstract]   [Full Text] [Related]  

  • 2. [Quantitative topography of aluminum in the rabbit with fibrillar degeneration of neurons in experimental encephalopathy].
    Smialek M
    Neuropatol Pol; 1967; 5(2):159-90. PubMed ID: 6046257
    [No Abstract]   [Full Text] [Related]  

  • 3. Aluminum metabolism and toxicity in uremia.
    Alfrey AC
    J UOEH; 1987 Mar; 9 Suppl():123-32. PubMed ID: 3602743
    [No Abstract]   [Full Text] [Related]  

  • 4. Comment on "the biological behaviour and bioavailability of aluminium in man" by N. D. Priest, JEM, 2004, 6, 375.
    Exley C
    J Environ Monit; 2005 Jun; 7(6):640; author reply 641-2. PubMed ID: 15931428
    [No Abstract]   [Full Text] [Related]  

  • 5. Aluminum: a role in degenerative brain disease associated with neurofibrillary degeneration.
    McLachlan DR; Van Berkum MF
    Prog Brain Res; 1986; 70():399-410. PubMed ID: 3554357
    [No Abstract]   [Full Text] [Related]  

  • 6. Aluminum toxicity in mammals: a minireview.
    Cannata JB; Domingo JL
    Vet Hum Toxicol; 1989 Dec; 31(6):577-83. PubMed ID: 2694586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental aluminium encephalopathy: quantitative EEG analysis of aluminium bioavailability.
    Cutrufo C; Caroli S; Delle Femmine P; Ortolani E; Palazzesi S; Violante N; Zapponi GA; Loizzo A
    J Neurol Neurosurg Psychiatry; 1984 Feb; 47(2):204-6. PubMed ID: 6707660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aluminum and neurodegenerative disease: therapeutic implications.
    McLachlan DR; Kruck TP; VanBerkum MF
    Am J Kidney Dis; 1985 Nov; 6(5):322-9. PubMed ID: 2865894
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study on the experimentally produced changes in the neurofibrils in animals, with special reference to electron microscopy findings].
    Ikuta F; Oyanagi S; Tanaka M
    Shinkei Kenkyu No Shimpo; 1968 Dec; 12(4):897-907. PubMed ID: 4980044
    [No Abstract]   [Full Text] [Related]  

  • 10. Aluminium(III) in experimental cell pathology.
    Zatta PF; Nicolini M; Corain B
    Ciba Found Symp; 1992; 169():186-97; discussion 197-200. PubMed ID: 1490422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aluminium induced osteomalacia and encephalopathy--an aberration of the tubulin assembly into microtubules (MTs) by Al3+?
    Schmidt R; Böhm K; Vater W; Unger E
    Prog Histochem Cytochem; 1991; 23(1-4):355-64. PubMed ID: 1947162
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial: Toxicity from aluminum antacids.
    Ulmer DD
    N Engl J Med; 1976 Jan; 294(4):218-9. PubMed ID: 1244535
    [No Abstract]   [Full Text] [Related]  

  • 13. [Aluminum in medicine. Application, toxicity, hazards].
    Becker G; Overhoff H
    Med Welt; 1980 Aug; 31(35):1228-33. PubMed ID: 7421557
    [No Abstract]   [Full Text] [Related]  

  • 14. Alterations in short-term retention, conditioned avoidance response acquisition and motivation following aluminum induced neurofibrillary degeneration.
    Crapper DR; Dalton AJ
    Physiol Behav; 1973 May; 10(5):925-33. PubMed ID: 4577243
    [No Abstract]   [Full Text] [Related]  

  • 15. Progressive dialytic encephalopathy and the problem of aluminum neurotoxicity.
    Bugiani O; Brancaccio D; Ghetti B
    Clin Nephrol; 1985; 24 Suppl 1():S20-5. PubMed ID: 3915956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aluminum encephalopathy in the rabbit studied by means of 75-Se-selenomethionine].
    Liwnicz BH
    Neuropatol Pol; 1967; 5(2):191-7. PubMed ID: 6046258
    [No Abstract]   [Full Text] [Related]  

  • 17. Aluminum inhibition of ADP-ribosylation in vivo and in vitro.
    McLachlan DR; Dam TV; Farnell BJ; Lewis PN
    Neurobehav Toxicol Teratol; 1983; 5(6):645-7. PubMed ID: 6422319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aluminum in tissues.
    Van de Vyver FL; De Broe ME
    Clin Nephrol; 1985; 24 Suppl 1():S37-57. PubMed ID: 3915959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular mechanisms of aluminium toxicity.
    Crapper McLachlan DR; Farnell BJ
    Ann Ist Super Sanita; 1986; 22(2):697-702. PubMed ID: 3530093
    [No Abstract]   [Full Text] [Related]  

  • 20. Short-term oral toxicity study of aluminium in rats.
    Gómez M; Domingo JL; Llobet JM; Tomás JM; Corbella J
    Arch Farmacol Toxicol; 1986; 12(2-3):145-51. PubMed ID: 3619503
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.